Zhu et al. found that METTL3 expression was significantly higher in RCC tissues than in adjacent normal tissues and that cell viability, migratory capacity, invasive capacity, and in vivo tumor formation were significantly inhibited when METTL3 was depleted [213]. The gene discussed is METTL3; the disease is neoplasm.